Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Title Fractioned CO2 Laser in the Treatment of Chronic Phase Peyronie's Disease — Stella

Home/Peyronies Disease/Title Fractioned CO2 Laser in the Treatment of Chronic Phase Peyronie's Disease

View on ClinicalTrials.gov

Recruiting

Back to Peyronies Disease trials

Title Fractioned CO2 Laser in the Treatment of Chronic Phase Peyronie's Disease

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Canada

The Ottawa Hospital, Ottawa, Ontario

Key details

Phase

Early testing

Sponsor

Ottawa Hospital Research Institute

Enrollment target

~60 participants

Started

October 2025

Primary completion

October 2027

Age range

18 Years and older

Sex

Male only

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.